Marksans Pharma Ltd (MARKSANS) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{ "main_header": { "sid": 604869, "name": "Marksans Pharma", "stock_name": "Marksans Pharma", "full_name": "Marksans Pharma Ltd", "name_url": "stocks-analysis/marksans-pharma", "exchange": 0, "exchangecode": "", "primexch": 1, "country_id": 34, "currency": "INR", "cmp": "175.00", "chg": 0.35, "chgp": "0.2%", "dir": 1, "prev_price": "174.65", "mcapval": "7,919.00 Cr", "mcap": "Small Cap", "scripcode": 524404, "symbol": "MARKSANS", "ind_name": "Pharmaceuticals & Biotechnology", "ind_code": 4, "indexname": "India SENSEX", "isin": "INE750C01026", "curr_date": "Apr 09", "curr_time": "", "bse_nse_vol": "5.85 lacs", "exc_status": "Active", "traded_date": "Apr 09, 2026", "traded_date_str": "2026 04 09", "score": "", "scoreText": "", "Live": 0, "market_time": 0, "is_blur": 1, "is_blur_class": "blur-register-score-header", "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/marksans-pharma-604869-0&utm_source=Spage_Header_Score", "mojoone": { "ismore": 0, "all_data": [] } }, "news": { "results": [ { "title": "Marksans Pharma Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3939397", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MarksansPharmaL_mojoScore_3939397.png", "date": "2026-04-09 10:10:32", "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 09 April 2026, providing investors with an up-to-date perspective on the company’s performance and outlook." }, { "title": "Marksans Pharma Ltd Technical Momentum Shifts Amid Mixed Market Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-technical-momentum-shifts-amid-mixed-market-signals-3936378", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MarksansPharmaL_technicaldot_3936378.png", "date": "2026-04-08 08:01:50", "description": "Marksans Pharma Ltd has experienced a nuanced shift in its technical momentum, with recent data indicating a transition from a bearish to a mildly bearish trend. Despite a modest day gain of 1.77%, the stock’s technical indicators present a complex picture, reflecting both cautious optimism and persistent headwinds in the Pharmaceuticals & Biotechnology sector." }, { "title": "Marksans Pharma Gains 3.29%: Key Market Moves and Technical Signals This Week", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-gains-329-key-market-moves-and-technical-signals-this-week-3932201", "imagepath": "", "date": "2026-04-04 16:08:19", "description": " <div class=\"article-news-new\">\n <div class=\"article-container\">\n\n<div class=\"article-content\">\n <div class=\"highlight-box\">\n <h3>Key Events This Week</h3>\n <p><strong>Mar 30:</strong> New 52-week low at Rs.156 amid downtrend</p>\n <p><strong>Apr 1:</strong> Intraday high of Rs.169.25 with 7.06% surge</p>\n <p><strong>Apr 2:</strong> Marginal gain to close at Rs.168.15</p>\n <p><strong>Apr 3:</strong> No trading data available; week closes at Rs.168.15 (+3.29%)</p>\n </div>\n\n <div class=\"stats-row\">\n <div class=\"stat-item\"><div class=\"stat-label\">Week Open</div><div class=\"stat-value\">Rs.162.80</div></div>\n <div class=\"stat-item\"><div class=\"stat-label\">Week Close</div><div class=\"stat-value\">Rs.168.15</div><div class=\"stat-ch..." }, { "title": "Marksans Pharma Ltd Surges 7.06% to Day's High of Rs 169.25 — Outperforms Sector by 6.15 Percentage Points", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-hits-intraday-high-with-706-surge-on-1-april-2026-3928970", "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/MarksansPharmaL_priceRelatedfactors_3928970.png", "date": "2026-04-01 11:31:14", "description": "The Sensex declined by 2.18% on 1 Apr 2026, yet Marksans Pharma Ltd surged 7.06%, outperforming its Pharmaceuticals & Biotechnology sector by 6.15 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment." }, { "title": "Five Consecutive Losses Push Marksans Pharma Ltd to a New 52-Week Low", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-stock-hits-52-week-low-amid-continued-downtrend-3925891", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MarksansPharmaL_priceRelatedfactors_3925891.png", "date": "2026-03-30 16:03:31", "description": "For the fifth consecutive session, Marksans Pharma Ltd has closed lower, hitting a fresh 52-week low of Rs 156 on 30 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper than its sector peers and the benchmark indices." }, { "title": "Marksans Pharma Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3921518", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MarksansPharmaL_mojoScore_3921518.png", "date": "2026-03-28 10:10:03", "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Marksans Pharma Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3896384", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MarksansPharmaL_mojoScore_3896384.png", "date": "2026-03-17 10:10:02", "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 07 July 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 17 March 2026, providing investors with the latest insights into its performance and prospects." }, { "title": "Marksans Pharma Ltd is Rated Sell", "link": "https://www.marketsmojo.com/news/stock-recommendation/marksans-pharma-ltd-is-rated-sell-3875693", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MarksansPharmaL_mojoScore_3875693.png", "date": "2026-03-06 10:10:02", "description": "Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance." }, { "title": "Marksans Pharma Ltd Technical Momentum Shifts Amid Bearish Signals", "link": "https://www.marketsmojo.com/news/stocks-in-action/marksans-pharma-ltd-technical-momentum-shifts-amid-bearish-signals-3868194", "imagepath": "https://i.marketsmojo.com/newsimg/2026/3/MarksansPharmaL_technicaldot_3868194.png", "date": "2026-03-04 08:03:42", "description": "Marksans Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects growing concerns over its price action and underlying market sentiment, despite its strong long-term returns relative to the Sensex." } ], "total": 341, "sid": "604869", "stock_news_url": "https://www.marketsmojo.com/news/marksans-pharma-604869" }, "announcements": [ { "caption": "Announcement under Regulation 30 (LODR)-Press Release / Media Release", "datetime": "01-Apr-2026", "details": "USFDA approval for Benzonatate Capsules USP 100 mg & 200 mg (Rx)", "source": "BSE" }, { "caption": "Closure of Trading Window", "datetime": "26-Mar-2026", "details": "Intimation of Closure of Trading Window for Quarter and Year ending March 31 2026", "source": "BSE" }, { "caption": "Announcement under Regulation 30 (LODR)-Newspaper Publication", "datetime": "12-Mar-2026", "details": "Newspaper publication regarding opening of special window for re-lodgement of the transfer request for physical shares", "source": "BSE" } ], "corporate_actions": [ { "img": "board-meeting.svg", "title": "BOARD MEETING", "msg": "<span>No</span> Upcoming Board Meetings", "data": [] }, { "img": "dividend.svg", "title": "DIVIDEND", "msg": "", "data": [ { "txt": "Marksans Pharma Ltd has declared <strong>80%</strong> dividend, ex-date: 01 Aug 25", "dt": "2025-08-01", "middle_text": "Dividend Alert" } ] }, { "img": "splits.svg", "title": "SPLITS", "msg": "", "data": [ { "txt": "Marksans Pharma Ltd has announced <strong>1:10</strong> stock split, ex-date: 11 Mar 08", "dt": "2008-03-11", "middle_text": "Split" } ] }, { "img": "bonus.svg", "title": "BONUS", "msg": "No <strong>Bonus</strong> history available", "data": [] }, { "img": "rights-issues.svg", "title": "RIGHTS", "msg": "No <strong>Rights</strong> history available", "data": [] } ] }

Key Events This Week

Mar 30: New 52-week low at Rs.156 amid downtrend

Apr 1: Intraday high of Rs.169.25 with 7.06% surge

Apr 2: Marginal gain to close at Rs.168.15

Apr 3: No trading data available; week closes at Rs.168.15 (+3.29%)

Read full news article

Marksans Pharma Ltd Surges 7.06% to Day's High of Rs 169.25 — Outperforms Sector by 6.15 Percentage Points

2026-04-01 11:31:14

The Sensex declined by 2.18% on 1 Apr 2026, yet Marksans Pharma Ltd surged 7.06%, outperforming its Pharmaceuticals & Biotechnology sector by 6.15 percentage points. This sharp single-session gain stands out as a stock-specific event amid a broadly weak market environment.

Read full news article

Five Consecutive Losses Push Marksans Pharma Ltd to a New 52-Week Low

2026-03-30 16:03:31

For the fifth consecutive session, Marksans Pharma Ltd has closed lower, hitting a fresh 52-week low of Rs 156 on 30 Mar 2026. This decline comes amid a broader market downturn, but the stock’s underperformance is notably sharper than its sector peers and the benchmark indices.

Read full news article

Marksans Pharma Ltd is Rated Sell

2026-03-28 10:10:03

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 28 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Marksans Pharma Ltd is Rated Sell

2026-03-17 10:10:02

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO. This rating was last updated on 07 July 2025, reflecting a reassessment of the stock’s outlook. However, the analysis and financial metrics discussed below represent the company’s current position as of 17 March 2026, providing investors with the latest insights into its performance and prospects.

Read full news article

Marksans Pharma Ltd is Rated Sell

2026-03-06 10:10:02

Marksans Pharma Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 07 July 2025. However, the analysis and financial metrics discussed here reflect the stock's current position as of 06 March 2026, providing investors with an up-to-date view of the company’s fundamentals, returns, and market performance.

Read full news article

Marksans Pharma Ltd Technical Momentum Shifts Amid Bearish Signals

2026-03-04 08:03:42

Marksans Pharma Ltd has experienced a notable shift in its technical momentum, with key indicators signalling a bearish trend. The company’s recent downgrade from a Hold to a Sell rating reflects growing concerns over its price action and underlying market sentiment, despite its strong long-term returns relative to the Sensex.

Read full news article